Dissecting the impact of bromodomain inhibitors on the Interferon Regulatory Factor 4-MYC oncogenic axis in multiple myeloma.
Saved in:
| Title: | Dissecting the impact of bromodomain inhibitors on the Interferon Regulatory Factor 4-MYC oncogenic axis in multiple myeloma. |
|---|---|
| Authors: | Agnarelli A; Biochemistry and Biomedicine, School of Life Sciences, University of Sussex, Brighton, UK., Mitchell S; Brighton and Sussex Medical School, University of Sussex, Brighton, UK., Caalim G; Biochemistry and Biomedicine, School of Life Sciences, University of Sussex, Brighton, UK., Wood CD; Biochemistry and Biomedicine, School of Life Sciences, University of Sussex, Brighton, UK., Milton-Harris L; Biochemistry and Biomedicine, School of Life Sciences, University of Sussex, Brighton, UK., Chevassut T; Brighton and Sussex Medical School, University of Sussex, Brighton, UK., West MJ; Biochemistry and Biomedicine, School of Life Sciences, University of Sussex, Brighton, UK., Mancini EJ; Biochemistry and Biomedicine, School of Life Sciences, University of Sussex, Brighton, UK. |
| Source: | Hematological oncology [Hematol Oncol] 2022 Aug; Vol. 40 (3), pp. 417-429. Date of Electronic Publication: 2022 May 18. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8307268 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1099-1069 (Electronic) Linking ISSN: 02780232 NLM ISO Abbreviation: Hematol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1099-1069 |
|---|---|
| DOI: | 10.1002/hon.3016 |
